Receptos Investor Sues To Block Celgene's $7.2B Buyout
A Receptos Inc. shareholder sued the San Diego biopharmaceutical company and Celgene Corp. on Monday seeking to block Celgene's proposed $7.2 billion buyout, saying Receptos' leaders breached their fiduciary duties by...To view the full article, register now.
Already a subscriber? Click here to view full article